Reported Tuberculosis in the United States, 2019
TB Treatment & Case Outcomes
Successful therapy completion for TB patients is a major performance indicator for TB programs. Among patients during 2017 who were alive at diagnosis, 89.8% had completed TB treatment successfully within one year.
Data collected by date and reason therapy was stopped (e.g., the patient completed therapy, or the patient died) were used to calculate completion of therapy percentages. Cases were stratified by the indicated length of therapy, based on American Thoracic Society, CDC, and Infectious Diseases Society of America treatment guidelines in effect during the period covered and the patient’s initial drug-susceptibility test results, age, and disease site.
- Percentages of TB Cases, by Initial Drug Regimen, Use of Directly Observed Therapy (DOT), and Completion of Therapy (COT): 1993–2019
- Reason TB Therapy Was Stopped: 1993–2017
- Sputum Culture Conversion: 2010–2017
- TB by Initial Drug Regimen: Reporting Areas, 2019
- Drug Resistance: Reporting Areas, 2019
- Directly Observed Therapy (DOT): Reporting Areas, 2017
- Reason TB Therapy Was Stopped: Reporting Areas, 2017
- Reason TB Therapy Was Extended: Reporting Areas, 2017
- Completion of TB Therapy (COT): Reporting Areas, 2017
- Persons Completing Therapy for Whom Therapy Was Indicated for ≤1 Year: Reporting Areas, 2013–2017
